Harmony Biosciences Holdings, Inc. (HRMY)
38.51
+0.36
(+0.94%)
USD |
NASDAQ |
Aug 24, 16:00
38.51
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Profit Margin (Quarterly) : 28.87% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.87% |
| March 31, 2026 | 15.08% |
| December 31, 2025 | 9.22% |
| September 30, 2025 | 21.24% |
| June 30, 2025 | 19.84% |
| March 31, 2025 | 24.66% |
| December 31, 2024 | 24.58% |
| September 30, 2024 | 24.78% |
| June 30, 2024 | 6.71% |
| March 31, 2024 | 24.79% |
| December 31, 2023 | 15.80% |
| September 30, 2023 | 24.00% |
| June 30, 2023 | 25.56% |
| March 31, 2023 | 24.75% |
| Date | Value |
|---|---|
| December 31, 2022 | 37.81% |
| September 30, 2022 | 75.03% |
| June 30, 2022 | 21.99% |
| March 31, 2022 | 25.18% |
| December 31, 2021 | 24.90% |
| September 30, 2021 | -11.92% |
| June 30, 2021 | 19.12% |
| March 31, 2021 | 12.38% |
| December 31, 2020 | -0.37% |
| September 30, 2020 | 4.19% |
| June 30, 2020 | -0.07% |
| March 31, 2020 | -194.7% |
| December 31, 2019 | -607.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Liquidia Corp. | 43.52% |
| Repligen Corp. | 2.45% |
| Johnson & Johnson | 21.86% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| ANI Pharmaceuticals, Inc. | 8.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.66% |
| Return on Assets | 14.54% |
| Return on Invested Capital | 16.52% |
| Gross Profit Margin (Quarterly) | 73.53% |
| Operating Margin (Quarterly) | 34.18% |
| Return on Net Operating Assets | 82.22% |